Showing 6 of 6 recruiting trials for “nut-midline-carcinoma”
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
👨⚕️ Giuseppe Procopio, MD, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy📍 1 site📅 Started May 2025View details ↗
Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma
👨⚕️ Xinan Sheng, MD., Peking University Cancer Hospital & Institute📍 2 sites📅 Started Feb 2024View details ↗
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
RecruitingNCT05265429 ↗
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →